The Lymphoma Signalling lab is led by Dr Robbert Hoogeboom. Dr Hoogeboom’s work focuses on the role of antigen exposure and B cell receptor signalling in the pathogenesis and treatment of B cell leukaemia and lymphoma. His team uses high content imaging of primary patient cells and novel in vivo mouse models to study the context in which malignant B cells see antigen and how antigen stimulation and BCR signalling influence the behaviour of the tumour cells and disease progression.
Our Partners
![The Kay Kendall Leukaemia Fund logo](/newimages/logos/kklf-logo-opaque.xf1b61204.png?f=webp)
The Kay Kendall Leukaemia Fund
![Leukaemia UK](/newimages/logos/leukaemia-uk.xaea7dbde.jpg?f=webp)
Leukaemia UK